Report cover image

Global Conjunctivitis Market Analysis and Forecast 2024-2030

Publisher APO Research, Inc.
Published Apr 26, 2024
Length 193 Pages
SKU # APRC18962137

Description

Global Conjunctivitis Market Analysis and Forecast 2024-2030


Summary

Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected.

According to APO Research, The global Conjunctivitis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Conjunctivitis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Conjunctivitis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Conjunctivitis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Conjunctivitis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Conjunctivitis include Novartis (CH), Santen Pharmaceutical (JP), Bausch & Lomb (US), Allergan (US), Sun Pharmaceutical (ID), Akorn (US), Freda (CN), Sinqi (CN) and Univision (CN), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Conjunctivitis, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Conjunctivitis, also provides the sales of main regions and countries. Of the upcoming market potential for Conjunctivitis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Conjunctivitis sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Conjunctivitis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Conjunctivitis sales, projected growth trends, production technology, application and end-user industry.

Conjunctivitis segment by Company

Novartis (CH)
Santen Pharmaceutical (JP)
Bausch & Lomb (US)
Allergan (US)
Sun Pharmaceutical (ID)
Akorn (US)
Freda (CN)
Sinqi (CN)
Univision (CN)
Conjunctivitis segment by Type

Antibiotic
Pills
Ointment
Conjunctivitis segment by End Use
r
Newborns
Children
Adults
Conjunctivitis segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Conjunctivitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Conjunctivitis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Conjunctivitis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Conjunctivitis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Conjunctivitis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Conjunctivitis sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Conjunctivitis Market by Type
1.2.1 Global Conjunctivitis Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Antibiotic
1.2.3 Pills
1.2.4 Ointment
1.3 Conjunctivitis Market by End User
1.3.1 Global Conjunctivitis Market Size by End User, 2019 VS 2023 VS 2030
1.3.2 Newborns
1.3.3 Children
1.3.4 Adults
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Conjunctivitis Market Dynamics
2.1 Conjunctivitis Industry Trends
2.2 Conjunctivitis Industry Drivers
2.3 Conjunctivitis Industry Opportunities and Challenges
2.4 Conjunctivitis Industry Restraints
3 Global Market Growth Prospects
3.1 Global Conjunctivitis Revenue Estimates and Forecasts (2019-2030)
3.2 Global Conjunctivitis Revenue by Region
3.2.1 Global Conjunctivitis Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Conjunctivitis Revenue by Region (2019-2024)
3.2.3 Global Conjunctivitis Revenue by Region (2025-2030)
3.2.4 Global Conjunctivitis Revenue Market Share by Region (2019-2030)
3.3 Global Conjunctivitis Sales Estimates and Forecasts 2019-2030
3.4 Global Conjunctivitis Sales by Region
3.4.1 Global Conjunctivitis Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Conjunctivitis Sales by Region (2019-2024)
3.4.3 Global Conjunctivitis Sales by Region (2025-2030)
3.4.4 Global Conjunctivitis Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Conjunctivitis Revenue by Manufacturers
4.1.1 Global Conjunctivitis Revenue by Manufacturers (2019-2024)
4.1.2 Global Conjunctivitis Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Conjunctivitis Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Conjunctivitis Sales by Manufacturers
4.2.1 Global Conjunctivitis Sales by Manufacturers (2019-2024)
4.2.2 Global Conjunctivitis Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Conjunctivitis Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Conjunctivitis Sales Price by Manufacturers (2019-2024)
4.4 Global Conjunctivitis Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Conjunctivitis Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Conjunctivitis Manufacturers, Product Type & Application
4.7 Global Conjunctivitis Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Conjunctivitis Market CR5 and HHI
4.8.2 2023 Conjunctivitis Tier 1, Tier 2, and Tier 3
5 Conjunctivitis Market by Type
5.1 Global Conjunctivitis Revenue by Type
5.1.1 Global Conjunctivitis Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Conjunctivitis Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Conjunctivitis Revenue Market Share by Type (2019-2030)
5.2 Global Conjunctivitis Sales by Type
5.2.1 Global Conjunctivitis Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Conjunctivitis Sales by Type (2019-2030) & (K Units)
5.2.3 Global Conjunctivitis Sales Market Share by Type (2019-2030)
5.3 Global Conjunctivitis Price by Type
6 Conjunctivitis Market by Application
6.1 Global Conjunctivitis Revenue by Application
6.1.1 Global Conjunctivitis Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Conjunctivitis Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Conjunctivitis Revenue Market Share by Application (2019-2030)
6.2 Global Conjunctivitis Sales by Application
6.2.1 Global Conjunctivitis Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Conjunctivitis Sales by Application (2019-2030) & (K Units)
6.2.3 Global Conjunctivitis Sales Market Share by Application (2019-2030)
6.3 Global Conjunctivitis Price by Application
7 Company Profiles
7.1 Novartis (CH)
7.1.1 Novartis (CH) Comapny Information
7.1.2 Novartis (CH) Business Overview
7.1.3 Novartis (CH) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Novartis (CH) Conjunctivitis Product Portfolio
7.1.5 Novartis (CH) Recent Developments
7.2 Santen Pharmaceutical (JP)
7.2.1 Santen Pharmaceutical (JP) Comapny Information
7.2.2 Santen Pharmaceutical (JP) Business Overview
7.2.3 Santen Pharmaceutical (JP) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Santen Pharmaceutical (JP) Conjunctivitis Product Portfolio
7.2.5 Santen Pharmaceutical (JP) Recent Developments
7.3 Bausch & Lomb (US)
7.3.1 Bausch & Lomb (US) Comapny Information
7.3.2 Bausch & Lomb (US) Business Overview
7.3.3 Bausch & Lomb (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Bausch & Lomb (US) Conjunctivitis Product Portfolio
7.3.5 Bausch & Lomb (US) Recent Developments
7.4 Allergan (US)
7.4.1 Allergan (US) Comapny Information
7.4.2 Allergan (US) Business Overview
7.4.3 Allergan (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Allergan (US) Conjunctivitis Product Portfolio
7.4.5 Allergan (US) Recent Developments
7.5 Sun Pharmaceutical (ID)
7.5.1 Sun Pharmaceutical (ID) Comapny Information
7.5.2 Sun Pharmaceutical (ID) Business Overview
7.5.3 Sun Pharmaceutical (ID) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Sun Pharmaceutical (ID) Conjunctivitis Product Portfolio
7.5.5 Sun Pharmaceutical (ID) Recent Developments
7.6 Akorn (US)
7.6.1 Akorn (US) Comapny Information
7.6.2 Akorn (US) Business Overview
7.6.3 Akorn (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Akorn (US) Conjunctivitis Product Portfolio
7.6.5 Akorn (US) Recent Developments
7.7 Freda (CN)
7.7.1 Freda (CN) Comapny Information
7.7.2 Freda (CN) Business Overview
7.7.3 Freda (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Freda (CN) Conjunctivitis Product Portfolio
7.7.5 Freda (CN) Recent Developments
7.8 Sinqi (CN)
7.8.1 Sinqi (CN) Comapny Information
7.8.2 Sinqi (CN) Business Overview
7.8.3 Sinqi (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Sinqi (CN) Conjunctivitis Product Portfolio
7.8.5 Sinqi (CN) Recent Developments
7.9 Univision (CN)
7.9.1 Univision (CN) Comapny Information
7.9.2 Univision (CN) Business Overview
7.9.3 Univision (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Univision (CN) Conjunctivitis Product Portfolio
7.9.5 Univision (CN) Recent Developments
8 North America
8.1 North America Conjunctivitis Market Size by Type
8.1.1 North America Conjunctivitis Revenue by Type (2019-2030)
8.1.2 North America Conjunctivitis Sales by Type (2019-2030)
8.1.3 North America Conjunctivitis Price by Type (2019-2030)
8.2 North America Conjunctivitis Market Size by End User
8.2.1 North America Conjunctivitis Revenue by End User (2019-2030)
8.2.2 North America Conjunctivitis Sales by End User (2019-2030)
8.2.3 North America Conjunctivitis Price by End User (2019-2030)
8.3 North America Conjunctivitis Market Size by Country
8.3.1 North America Conjunctivitis Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Conjunctivitis Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Conjunctivitis Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Conjunctivitis Market Size by Type
9.1.1 Europe Conjunctivitis Revenue by Type (2019-2030)
9.1.2 Europe Conjunctivitis Sales by Type (2019-2030)
9.1.3 Europe Conjunctivitis Price by Type (2019-2030)
9.2 Europe Conjunctivitis Market Size by End User
9.2.1 Europe Conjunctivitis Revenue by End User (2019-2030)
9.2.2 Europe Conjunctivitis Sales by End User (2019-2030)
9.2.3 Europe Conjunctivitis Price by End User (2019-2030)
9.3 Europe Conjunctivitis Market Size by Country
9.3.1 Europe Conjunctivitis Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Conjunctivitis Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Conjunctivitis Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Conjunctivitis Market Size by Type
10.1.1 China Conjunctivitis Revenue by Type (2019-2030)
10.1.2 China Conjunctivitis Sales by Type (2019-2030)
10.1.3 China Conjunctivitis Price by Type (2019-2030)
10.2 China Conjunctivitis Market Size by End User
10.2.1 China Conjunctivitis Revenue by End User (2019-2030)
10.2.2 China Conjunctivitis Sales by End User (2019-2030)
10.2.3 China Conjunctivitis Price by End User (2019-2030)
11 Asia (Excluding China)
11.1 Asia Conjunctivitis Market Size by Type
11.1.1 Asia Conjunctivitis Revenue by Type (2019-2030)
11.1.2 Asia Conjunctivitis Sales by Type (2019-2030)
11.1.3 Asia Conjunctivitis Price by Type (2019-2030)
11.2 Asia Conjunctivitis Market Size by End User
11.2.1 Asia Conjunctivitis Revenue by End User (2019-2030)
11.2.2 Asia Conjunctivitis Sales by End User (2019-2030)
11.2.3 Asia Conjunctivitis Price by End User (2019-2030)
11.3 Asia Conjunctivitis Market Size by Country
11.3.1 Asia Conjunctivitis Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Conjunctivitis Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Conjunctivitis Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Conjunctivitis Market Size by Type
12.1.1 MEALA Conjunctivitis Revenue by Type (2019-2030)
12.1.2 MEALA Conjunctivitis Sales by Type (2019-2030)
12.1.3 MEALA Conjunctivitis Price by Type (2019-2030)
12.2 MEALA Conjunctivitis Market Size by End User
12.2.1 MEALA Conjunctivitis Revenue by End User (2019-2030)
12.2.2 MEALA Conjunctivitis Sales by End User (2019-2030)
12.2.3 MEALA Conjunctivitis Price by End User (2019-2030)
12.3 MEALA Conjunctivitis Market Size by Country
12.3.1 MEALA Conjunctivitis Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Conjunctivitis Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Conjunctivitis Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Conjunctivitis Value Chain Analysis
13.1.1 Conjunctivitis Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Conjunctivitis Production Mode & Process
13.2 Conjunctivitis Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Conjunctivitis Distributors
13.2.3 Conjunctivitis Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.